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Section I: Introduction 
 Recent health care policy reforms have prompted an increased interest in the efficiency of 
the US health care system.  Comparing the US to 23 other Organisation for Economic Co-
operation and Development (OECD) member countries at similar levels of development, one 
finds that the health expenditure of the US far exceeds that of its peers.  In 2006, the US spent 
approximately 15.8% of its GDP on health care, more than any other OECD country and 
considerably larger than the 9.1% average of its peer nations (OECD Health Data, 2009). The 
important question to ask then is whether or not this additional expenditure pays off in higher 
health outcomes. Unfortunately, based on average life expectancies alone, this does not seem to 
be the case. The US had the lowest female and male life expectancies at birth of the same 24 
OECD countries in 2006. The US female life expectancy at birth was 80.7 years (tied with 
Denmark), falling 2.1 years below the average of 82.8 years; the US male life expectancy at birth 
was 75.4 years, again, falling 2 years below the average of 77.4 years (OECD Health Data, 
2009). This raw and partial evidence suggests that the US health care system may be performing 
inefficiently compared to its peer nations. 
 Of course, there are many factors outside of health care that effect life expectancy at birth 
such as lifestyle choices regarding the consumption of tobacco, alcohol, and in-nutritious foods, 
pollution levels, external causes of death from accidents or crime, and socioeconomic factors 
such as GDP per capita or average education levels (Joumard, Isabelle et al., 2008). It is 
therefore not correct to assume that inefficient health care is the sole cause of low life 
expectancies in the US without taking these other factors into account. Therefore, the purpose of 
my research is to analyze the efficiency of the US health care system factoring in these outside 
effects. I accomplish this through a panel data analysis of 24 OECD countries (including the US) 
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spanning the years 1960 to 2006. I first use an Ordinary Least Squares (OLS) regression of a 
Cobb-Douglas production function to rank the countries based upon country dummy variable 
coefficients. I then extend upon my econometric methods by utilizing a time invariant frontier 
model to generate efficiency estimates. I improve upon previous estimates by utilizing the most 
recent data available, including better and more specific proxies for certain variables, and only 
including countries whose performance is truly comparable to that of the US by removing low 
performing outliers that fall into a separate efficiency and income bracket. 
 The format of my paper is as follows: Section II provides a review of previous literature 
on the topic of health care system efficiency, Section III summarizes the econometric methods 
utilized, Section IV outlines my data and empirical model, Section V reports my results, Section 
VI offers a summation of my findings and Section VII suggests potential avenues for further 
research. 
Section II: Literature Review 
 Several studies have sought to compare the efficiency of health care systems of OECD 
countries in recent years. Most empirical studies have focused on assessing and comparing the 
efficiency of all OECD countries without specific attention to the relative performance of a 
particular nation. For this reason, most studies include all OECD countries for which the desired 
variables are available over the desired period. Looking at the efficiency of all OECD nations 
however, ignores differences in income and health outcomes that place certain nations in a 
separate peer group. GDP per capita among the OECD countries in 2006 ranged from a little 
over 7,000 US$ to a little over 72,000 US$. One cannot reasonably expect nations at such 
different levels of development to have comparable health outcomes.  
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A recent OECD working paper used several measures to analyze the efficiency of OECD 
nations and found that the countries could be separated into three different groups based on 
health outcome results. The lowest group included the Czech Republic, Hungary, Mexico, 
Poland, the Slovak Republic, and Turkey (Joumard et al., 2008). This group had average life 
expectancies at birth that were four to five years lower than the average of the second 
performance group and had over seven more infant mortalities per 1,000 live births on average 
than the second performance group (Joumard et al., 2008). The differences between the second 
and first performance groups were much less extreme with differences in average life 
expectancies of about two years and differences in average infant mortality rates of less than one 
death per 1,000 live births (Joumard et al., 2008). The results of this study confirm that not all 
OECD countries are comparable when considering health outcomes. 
Health Care Outputs 
A major matter of debate in health system efficiency analysis is what variable is best to 
use as the output of a health care production function. Most studies contend that health outcomes 
are better to use than measures of health care activity such as the number of physician visits or 
CT scans, etc. performed (Garber and Skinner, 2008; Joumard et al., 2008; Or, Wang, and 
Jamison, 2004). Or, Wang and Jamison suggest that focusing efficiency analysis on measures of 
health care activity doesn’t look at the goal of health care, which is to improve patient health 
(2004). There is also a general consensus that health care activity analysis leads to negative 
incentives of overuse in health care as countries try to increase the quantity rather than the 
quality of health care provided. Even though it is largely agreed upon that health outcomes are a 
more accurate and appropriate measure of health care outputs, the vast array of potential 
measures of health outcomes leads to questions of which measure is best to use. 
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Measures of mortality rates and average life expectancies are the most widely available 
measures of overall health outcomes to date. The main problem with these measures however is 
the lack of specificity as to the inputs that go into them. A person’s life expectancy is determined 
by many factors outside of health care such as lifestyle choices, pollution, and external causes 
like accidents and murder. It is difficult to separate the effects of these non-health-care-related 
components from the effects of health care. Several studies have thus looked at specific case 
studies of survival rates after or treatment of specific diseases (Preston and Ho, 2009). While 
these measures provide strong data on the effectiveness of specific health care treatments across 
countries, they cannot be expected to provide information on the overall efficiency of a health 
care system (Joumard et al., 2008). Therefore, despite the over-inclusiveness of mortality 
measures, most studies find that they are the best proxies of health outcomes currently available 
(Joumard et al., 2008; Or, Wang, and Jamison, 2004). By controlling for as many of the non-
health-care-related inputs to life expectancy as possible, one can hope to ascertain a fairly 
accurate picture of the specific effects of the health care industry on patient life expectancy. 
Health Care System Inputs 
Studies vary in their choices of medical inputs as well. Most use either the number of 
physicians, hospital beds, or CT scanners as physical measures of inputs or use total, public, or 
private health expenditure as monetary measures of inputs, but few have used both physical and 
monetary measures simultaneously. Physical and monetary input measures are generally seen as 
substitute proxies for health care inputs. For example, Wang, Jamison, and Or use the number of 
practicing physicians per 1,000 people because they did not feel that adequate measures of health 
expenditure were available (2004). Joumard et al. run separate regressions using the number of 
practicing physicians in one set of regressions and total health expenditure in the other set 
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(2008). Joumard et al. claim that increases in total health expenditure leads to more practicing 
physicians, but this statement only holds under the assumption that the wages paid to physicians 
are equal across countries, which is not the case. An increase in total expenditure of 155,000 US$ 
would buy Germany two more physicians while it would not even pay for one extra physician in 
the United States according to the average physician incomes reported by Garber and Skinner 
from the OECD 2007 Health Data (2008). It therefore seems acceptable to use the number of 
practicing physicians as a proxy for labor inputs and total health expenditure as a proxy for other 
health care inputs as well as for the emphasis placed on healthcare by each country. 
Socioeconomic and Environmental Controls 
The most common socioeconomic and environmental control variables used in recent 
studies have been pollution, education levels, and GDP per capita (Joumard et al., 2008; Or, 
Wang, and Jamison, 2004). Air pollution, particularly in the form of Nitrogen Oxide, Sulfur 
Oxide, and Carbon Monoxide, has been found to create respiratory and cardiovascular issues, 
sometimes resulting in serious ailments or even death, in high concentrations (Chen et al., 2007; 
Leslie et al., 1978). It is possible then, that low concentrations of these toxins associated with 
ambient levels of air pollution could also have negative effects. Unfortunately, measures of 
pollution levels of these chemicals have only been collected since 1990 which makes their 
utilization in a time series analysis difficult (OECD 2009 Health Data).  
GDP per capita and average education levels have also been found in previous studies to 
have a significant impact on health outcomes. Although education has been found to have a 
positive correlation to average life expectancies, the direction of causation is currently under 
debate (Joumard et al., 2008). Measures of educational attainment are also not widely available 
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over time limiting their use in panel data analyses. GDP per capita has been found to be 
positively linked to health outcomes as well (Joumard et al., 2008; Or, Wang, Jamison, 2004). 
Countries with higher GDP per capita levels can afford better medical technology and 
pharmaceuticals which contribute positively to health outcomes. Citizens of high income 
countries are also more likely to have access to sanitary living conditions such as clean water, 
plumbing, and waste disposal systems. These factors along with many others cause higher GDP 
per capita levels to be positively correlated to health outcomes and the long running collection of 
income data among developed countries make this variable useful in panel data analyses (OECD 
2009 Health Data). 
One demographic variable that has not been considered in many previous studies is the 
age dependency ratio of a nation. Age dependency is the number of individuals who are 14 and 
younger or 65 and older divided by the number of individuals who are 15 to 64 (OECD Health 
Data, 2009). It thus measures the number of people needing assistive care versus those who must 
provide that care. A high age dependency ratio could increase the burden on health care systems 
as individuals of dependent age tend to have lower immune systems and are therefore more 
susceptible to contracting diseases. It therefore seems likely that a country with a high age 
dependency ratio could experience lower levels of health and thus, lower life expectancies. 
Lifestyle Controls  
Common lifestyle controls utilized in previous literature are tobacco and alcohol 
consumption along with diet and exercise (Joumard et al., 2008; Or, Wang, and Jemison, 2004). 
A problem area in recent studies involves the proxies used for diet and exercise. Or, Wang, and 
Jamison completely neglect this variable in their study (2004) and Joumard et al. use the number 
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of fruits and vegetables consumed as a proxy for diet and exercise (2008). However, Joumard et 
al. have problems with the significance and robustness of the variable due to time lag issues. 
Other studies have also found that Fruit and Vegetable intake has a significant effect on weight 
gain only when it can be lagged over a period longer than four years (Buijsse et al., 2009).  A 
person’s diet now is likely to have stronger effects on her future health than it does on her current 
health. An overweight and diabetic individual who has consumed unhealthy foods and exercised 
little throughout her life but has recently begun to improve her diet through the increased 
consumption of fruits and vegetables is unlikely to see a change in her health status for some 
time. Simply measuring the consumption of fruit and vegetables does not account for these 
lagged effects. 
Obesity is a much better proxy for diet and exercise since it measures the current negative 
health effects of an extended period of poor diet and exercise. However, differences in 
measurement techniques among various nations make this variable unusable in current studies. 
Because the US has high obesity rates compared to the other nations for which the data are 
available (OECD 2009 Health Data), it is imperative to take diet and exercise into consideration 
in order to get an accurate measure for health care efficiency. Sugar consumption is not as 
commonly considered but could also have negative effects on health outcomes and may be a 
better proxy for overall eating habits than fruit and vegetable consumption. One study looks at 
the effects of consuming sugar-sweetened soft drinks on weight gain and finds some evidence for 
increased weight gain in women over extended periods of time from increased consumption 
(Nissinen et al., 2009). An individual with a high sugar intake may be more likely to have a poor 
diet overall, and a poor diet can lead to many negative health effects including diabetes and 
cardiovascular issues (Buijsse et al., 2009). 
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Section III: Methods 
The Basic Model 
 I use a Cobb-Douglas production function to analyze the efficiency of the US health care 
system compared to its peer nations. A production function allows me to assess the efficiency 
with which a nation uses its health care inputs to produce health outputs. A Cobb-Douglas 
production function is of the generic form 
   
where Y represents output, L represents labor inputs, K represents capital inputs, and A is a 
technological parameter. In the context of health care efficiency, the theoretical model that I 
regress is 
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where socioeconomic controls include demographic information as well as institutional 
parameters and lifestyle controls include tobacco and alcohol use along with diet and exercise. 
Representing health outcomes as HO, socioeconomic controls as SC, and lifestyle controls as 
LC, and transposing the equation into log linear form for the sake of estimation, we have 
ln 	#$   % &' ln #$ % &( ln #$ % &) ln *+#$ % &, ln +#$ % -#$ 
where εit is the error term of country i in time t. 
OLS Regressions with Country Dummy Coefficients 
 In my initial analysis, I run OLS regressions of the basic form above, including country 
dummy variables to pick up country-specific differences in health outcomes. In this analysis, the 
coefficients of the descriptive independent variables are not as important as the coefficients of 
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the country dummy variables. These coefficients indicate the differences in health outcomes 
between countries that cannot be explained by variations in the control variables and can thus be 
used as estimates of efficiency.  
By making the US the excluded country in the regressions, significant coefficients of the 
dummy variables can be taken to indicate differences in health outcomes from those of the US 
due to inefficiency. A positive significant coefficient for a given country dummy indicates that 
that country has higher health outcomes than those of the US holding all other factors in the 
model constant. Variables with negative significant coefficients experience lower health 
outcomes than those of the US holding other factors constant. Insignificant coefficients indicate 
that there is not a significant difference between the health outcomes of the given country and 
those of the US. The countries can then be ranked based on the magnitude and significance of 
their country dummy coefficients to indicate their level of productivity in health care. The 
highest ranked country is considered to be performing at maximum efficiency. It is then assumed 
that all countries lying below the highest in rank could improve their health outcomes while 
maintaining the same levels of inputs by increasing their productivity. 
This form of analysis has the drawback that country dummy variables pick up all effects 
not controlled for in the model, not just inefficiency. To account for this, I try to include as many 
control variables as possible. I also conduct further analyses that are more technically sound in 
order to compare my results to those of the OLS regressions. The method I choose to enact for 
further analysis is a time invariant frontier model. 
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Stochastic Frontier Analysis 
 Most forms of econometric analysis look primarily at the size and significance of the 
coefficients of the independent variables in the model along with the ability of the model to 
explain changes in the dependent variable. The residual is usually only considered enough to 
ensure that it is normally distributed and not serially correlated. In Stochastic Frontier Analysis 
(SFA) however, the residual becomes the most important part of the regression process (Jacobs, 
Smith, and Street, 2006). SFA, which is primarily used to analyze production functions, assumes 
that all or part of the residual is due to inefficiency. The most basic form of this analysis, called 
corrected ordinary least squares (COLS), assumes that the entire residual is due to inefficiency 
rather than model error (Jacobs, Smith, and Street, 2006). The country with the largest positive 
residual is assumed to be performing at 100% efficiency. The line of best fit is then shifted up to 
run through this maximum efficiency country, generating a production frontier. The other 
countries will all be inside this frontier and can be ranked according to how far inside each 
country lies (Jacobs, Smith, and Street, 2006).   
Because no econometric model is without error, the model residual should really not be 
considered to be entirely due to inefficiency. Therefore, several more advanced methods have 
been developed in order to adjust for random error. In advanced SFA, it is assumed that the 
residual has two main components, one due to random model error, and one due to inefficiency 
(STATAXT). There have been many methods developed to dissect the residual into these two 
components. In almost all cases, the components are broken down by assuming that the random 
error term is normally distributed and then by placing various constraints on the distribution of 
the inefficiency term.  
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Using panel data helps in the estimation of inefficiency by providing multiple data points 
for each country, thereby providing better estimates for both the inefficiency term and 
explanatory variables included in the model (Jacobs, Smith, and Street, 2006). One of the 
simplest advanced SFA methods available for panel data assumes that the inefficiency term does 
not vary over time (Jacobs, Smith, and Street, 2006). This assumption can be challenged since 
increases in technology over time often improve efficiency; however, further analyses are 
beyond the scope of this paper. Time invariant SFA assumes that the random component of the 
error term is normally distributed with zero mean and that the inefficiency term has a truncated 
normal distribution (STATAXT). Efficiency estimates are generated from the broken down 
inefficiency term, signifying each country’s variation from the estimated production frontier. 
Countries can then be ranked based on their estimated levels of efficiency (Jacobs, Smith, and 
Street, 2006). SFA improves upon the OLS method because it does not rely upon country dummy 
variables to generate efficiency estimates and because it better utilizes the available panel data.  
Section IV: Data 
My data come from the OECD 2009 Health Data set. Table 1 lists the 30 OECD member 
countries ranked first by GDP per capita and then by average life expectancies of both females 
and males at birth. The countries in bold are the ones included in the study. I eliminate the six 
countries mentioned in Section II from my analysis since their performance has been found to be 
incomparable to that of the other nations included in the study. Table 1 also clearly displays that 
these nations are fundamentally different, both in their income levels and health outcomes, than 
the included nations. Furthermore, the average GDP per capita of the 24 OECD countries in the 
analysis was 40,188 US$ in 2006 which is comparable to the 43,904 US$ average GDP per 
capita of the US from the same year. This indicates that the nations included in the study 
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represent countries at comparable development levels, in terms of GDP per capita, to that of the 
US (OECD 2009Health Data).  
Table 1: OECD Countries Sorted by GDP, LEFB, and LEBM 
Country GDP per capita LEFB LEMB Sorted by LEFB Sorted by LEMB 
NORW 72,282 82.9 78.2 JAPAN ICE 
LUX 67,932 81.9 76.8 SPAIN SWITZ 
ICE 54,672 83.0 79.4 SWITZ JAPAN 
IRE 52,354 82.2 77.4 ITAL AUS 
SWITZ 52,062 84.2 79.2 FRAN SWED 
DEN 50,366 80.7 76.1 AUS ITAL 
 
US 43,904 80.7 75.4 FIN CAND 
SWED 43,284 82.9 78.7 ICE NORW 
NETH 41,289 81.9 77.6 CAND NEW 
UK 40,403 81.7 77.3 NORW SPAIN 
FIN 39,636 83.1 75.9 SWED NETH 
CAND 39,315 83.0 78.4 AUST IRE 
 
AUST 38,833 82.7 77.1 GERM UK 
AUS 37,980 83.5 78.7 KOR FRAN 
BELG 37,733 82.3 76.6 BELG GERM 
FRAN 35,751 84.1 77.2 PORT AUST 
GERM 35,231 82.4 77.2 IRE GRE 
JAPAN 34,144 85.8 79.0 NEW LUX 
 
ITAL 31,774 84.2 78.5 GRE BELG 
SPAIN 27,863 84.4 77.7 LUX DEN 
NEW 25,742 82.2 78.0 NETH FIN 
GRE 23,904 82.0 77.1 UK KOR 
KOR 19,707 82.4 75.7 DEN PORT 
PORT 18,355 82.3 75.5 US US 
 
CZEC 13,880 79.9 73.5 CZEC CZEC 
HUN 11,226 77.4 69.0 POL MEX 
SLOV 10,364 78.2 70.4 SLOV TURK 
MEX 9,016 77.2 72.4 HUN POL 
POL 8,967 79.6 70.9 MEX SLOV 
TURK 7,268 75.3 71.1 TURK HUN 
 
13 
 
Health Care Outputs 
As a proxy for health outcomes, I run separate regressions using the average life 
expectancies of men and women both at birth and at age 60 since a large portion of health 
expenditure is spent on senior citizens (Joumard et al., 2008).  
Health Care System Inputs 
I use the number of practicing physicians as well as total health expenditure as measures 
of health care inputs for the reasons stated in the literature review. I run separate regressions 
using the number of practicing general practitioners and the total number of practicing 
physicians as the proxy for labor. I do this because of the growing international concerns that 
there will be shortages of general practitioners in the near future. It is possible that the ratio of 
general practitioners to specialists contributes significantly to improving the health outcomes as 
well as the cost effectiveness of a health care system. Thus, analyzing the effects of total 
physicians on health outcomes as opposed to the specific effects of the number of general 
practitioners could indicate what the more important factor in improving health outcomes is: 
increasing the total number of physicians without regard to whether they are general practitioners 
or specialists, or particularly increasing the number of general practitioners. 
Socioeconomic and Environmental Controls 
As socioeconomic controls, I include GDP per capita and educational attainment at the 
secondary level, both of which have been found to be significant in previous studies. I also 
include the age dependency ratio of each nation in order to compensate for demographic 
differences in the age distribution of various populations that could affect health outcomes. I do 
not include measures for institutional differences in health care systems because it is too difficult 
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to disentangle the combinations of institutional frameworks enacted by individual countries 
(Joumard et al., 2008). As environmental controls, I utilize measures of ambient levels of air 
pollution in the form of sulfur oxide, nitrogen oxide, and carbon monoxide. 
Lifestyle Controls 
As lifestyle controls, I include tobacco, alcohol, and sugar consumption. To correct for 
missing data in tobacco consumption, linear regressions are run analyzing changes in 
consumption over time and the fitted values from the regressions were used in place of the actual 
data. The available measure of sugar consumption only takes into account the consumption of 
refined sugars and does not include artificial sweeteners or high fructose corn syrup. While this 
proxy neglects a large portion of sweetener consumption, at least in the US, that also has 
negative health effects; the consumption of refined sugar alone has been found to lead to 
numerous health issues, and so gives some indication of the negative health effects of a poor diet.  
Empirical Model 
My empirical model is as follows:  
ln .#$   % &' ln /#$ % &( ln 	
.01#$ % &) ln 23#$ % &, ln #$ % &4 ln *5#$ %
&6 ln 5
7
1#$ % &8 ln *
9 #$ %  &: ln /#$ % &; ln <7/#$ % &'=+7
 % -#$  
 
The variable Phys indicates the total number of practicing physicians and the number of 
practicing general practitioners in separate regressions. LE indicates life expectancy at birth and 
at age 60 for both men and women with separate regressions run for each. Pollution indicates 
separate variables for nitrogen oxide, sulfur oxide, and carbon monoxide. I run separate 
regressions including and excluding Sugar in order to assess the differences in the efficiency 
estimates of the US when taking diet and exercise into account. CountryDummies represents 
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separate dummy variables for each country with the US as the excluded case. The brunt of my 
initial analysis will be formed from the values of these coefficients. Table 2 provides the 
descriptive statistics of my dependent and independent variables. 
Table 2: Descriptive Statistics      
Variable Description n Mean Std. Dev. Min Max 
Dependent Variables     
LEFB Life expectancy of females at birth 
(Years) 
1010 78.293 3.4539 53.7 86.0 
LEF60 Life expectancy of females at age 60 
(Years) 
991 22.078 2.0830 17.5 28.1 
LEMB Life expectancy of males at birth 
(Years) 
1010 72.083 3.7486 51.1 79.7 
LEM60 Life expectancy of males at age 60 
(Years) 
996 17.989 1.9989 12.7 22.6 
 
    Independent Variables     
Phys (+) Total Practicing Physicians 
(Density per 1,000 people) 
843 2.1845 .89337 .50 5.35 
GenPrac (+) Practicing General Practitioners 
(Density per 1,000 people) 
592 .8839 .45347 .19 2.12 
HealthExp (+) Total expenditure on health  
(% of GDP) 
961 7.150 2.1376 1.5 16.0 
       
Nitrogen (-) Total nitrogen oxide emissions 
(kg per capita) 
383 40.65 22.634 12 115 
Sulfur (-) Total sulfur oxide emissions 
(kg per capita) 
383 28.47 27.318 2 141 
Carbon (-) Total carbon monoxide emissions 
(kg per capita) 
383 135.19 105.638 17 548 
       
GDP (+) GDP per capita  
(US$ exchange rate) 
1097 14789.45 13400.25 276 82520 
Second (+) Ed. attainment at upper secondary level 
(% population) 
234 41.09 12.615 10 64 
AgeDep (-) 
 
Age dependency ratio 
(Pop 0-14 & 65+ / Pop 15-64 yrs old, %) 
1133 53.721 7.6283 38.8 88.8 
       
Alcohol (-) Alcohol consumption of those 15+  
(liters per capita) 
1018 10.421 3.6635 2.5 20.8 
Tobacco (-) Tobacco consumption 
(% population who smoke daily) 
503 31.793 9.0686 14.5 61.0 
Sugar (-) Sugar consumption 
(kilos per capita) 
989 41.972 11.4483 1.6 71.9 
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Section V.I: OLS Regression Results 
The full results of the OLS regressions are listed in Tables A1 and A2 in the appendix. 
Greece, Japan, Korea, Luxembourg, and Spain are removed from the analysis due to data 
availability, leaving 19 OECD countries, including the US, in the data set.  
The regressions including LnPhys as the variable for labor (Table A1) have less 
descriptive merit than those including LnGenPract (Table A2). The coefficients for sugar 
consumption (when included) and health expenditure in the regressions run with LnPhys were 
almost always found to be insignificant and/or to have the incorrect sign. The total number of 
physicians itself was also found to be insignificant or to have the wrong sign. These results 
support the hypothesis that the number of general practitioners has a more significant impact on 
patient health outcomes than the total number of physicians alone. For these reasons, the results 
from the regressions including LnPhys have been excluded from further analysis. The results can 
be seen in Table A2 in the appendix. The results discussed here only include results from the 
regressions run with LnGenPract as the indicator for labor.  
The number of general practitioners has a positive significant impact on the life 
expectancies of females both at birth and at age 60. The number of general practitioners only has 
a significant impact on male life expectancies when sugar consumption is included in the model. 
As expected, total health expenditure has a significant positive impact on the life expectancies of 
both women and men at birth and at age 60. The significance of both variables suggests that it is 
acceptable to use the number of general practitioners as a proxy for labor along with total health 
expenditure as a proxy for other health inputs simultaneously. 
GDP per capita has a positive impact on the life expectancies of females, but, 
surprisingly, is negatively correlated with the life expectancies of males. This could be explained 
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by changes in diet and daily physical exertion that accompany increased income levels. Because 
white-collar jobs often pay higher wages than more labor intensive trades, it is possible that men 
with higher incomes are less active on a daily basis than those at lower income levels. Men with 
higher incomes are also able to hire workers to perform manual labor at home like construction 
projects and yard work, thus further decreasing activity levels. Increased income could also 
increase one’s calorie intake as food becomes more readily affordable. On the other hand, 
because this study spans the years 1960 to 2008, it is likely that increases in GDP per capita 
signify increased activity for women as they began to work outside of the home, often while still 
maintaining their domestic activities. 
Educational attainment as well as pollution levels are insignificant and interfere with the 
model. These variables are only available for a short period of time relative to the other variables 
in the study, so including them in the model greatly decreases the degrees of freedom which 
could be the cause of their insignificance. The short duration of the available data also make time 
lags for these variables impossible to implement. They have thus been dropped from the analysis. 
Tobacco consumption has a significant negative impact on the life expectancies of both 
men and women at birth and at age 60. The coefficients of this variable are by far the largest of 
the descriptive independent variables in the model, implying that, if tobacco consumption could 
be decreased, the positive impact on health outcomes could be dramatic.  Alcohol consumption 
has a significant negative impact on the life expectancies of women, but not on men. Given that 
men are larger than women on average and that alcohol tolerance is proportional to size, it is 
understandable that alcohol consumption would not have as big of an effect on the health 
outcomes of men as on those of women.  
18 
 
Separate regressions are run including and excluding sugar consumption in order to 
assess its effect on the efficiency estimates of the US. The regressions including LnSugar have 
more descriptive merit and, overall, the sizes of the coefficients of the other descriptive 
independent variables do not change drastically when the variable is included. Sugar 
consumption itself has a significant negative impact on all measures of life expectancy, 
supporting the hypothesis that poor diet, indicated by increased sugar consumption, contributes 
to poor health.  
It is relevant to note that the coefficients for all of the descriptive independent variables 
are percent changes in life expectancy given a 1% change in the associated variable because the 
model has been transposed into natural log form. Given an average life expectancy of 80 years, a 
5% change would increase life expectancy by 4 years. It is difficult to calculate the value of four 
extra years of life but, for most people, this difference would likely be considered rather large. If 
four years does not seem important, consider that there is a relatively small difference between 
life expectancies among developed nations to begin with. The difference between the highest and 
lowest values for female life expectancy at birth of the countries included in the study is only 4.1 
years. Likewise the difference for male life expectancy at birth between the highest and lowest 
values is 3.9 years. The variance in life expectancy at age 60 is even smaller. Small coefficients 
are thus explained by the relatively small variance among developed nations in health outcomes. 
 Table 3 lists the country dummy variables in order of the magnitude and significance of 
their estimated coefficients. As stated in Section III, the US is the excluded case, so positive 
coefficients describe health outcomes above those of the US and negative coefficients describe 
health outcomes below those of the US. The US has therefore been placed in the rankings at the 
point between positive and negative coefficients. Countries that do not have a significant 
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difference in health outcomes from that of the US are still ranked according to the magnitude of 
their coefficients, though these rankings are somewhat arbitrary. In each case, the US has been 
circled to highlight its placement.  
Table 3: Country Ranks from OLS Regressions 
LEFB  LEF60  LEMB  LEM60 
No Sugar Sugar  No Sugar Sugar  No Sugar Sugar  No Sugar Sugar 
SWITZ*** SWITZ***  SWITZ*** SWITZ***  ICE*** ICE***  ICE*** ICE*** 
SWED*** SWED***  FRAN*** FRAN***  SWED*** SWED***  SWITZ*** SWITZ*** 
ITAL*** NETH***  ITAL*** NETH***  SWITZ*** SWITZ***  SWED*** SWED*** 
FRAN*** ICE***  SWED*** SWED***  NETH*** NETH***  CAND*** CAND*** 
NETH*** FRAN***  NETH*** ITAL***  ITAL*** NORW***  ITAL*** AUS* 
           
ICE*** ITAL***  CAND*** CAND***  NORW*** AUS***  FRAN*** NEWZ 
CAND*** CAND***  AUS*** NEWZ***  AUS*** CAND***  AUS*** NORW 
FIN*** AUS***  NEWZ*** AUS***  CAND*** UK***  NORW*** ITAL 
NORW*** NORW***  ICE*** ICE***  UK*** ITAL***  NEWZ** FRAN 
AUS*** NEWZ***  FIN*** NORW***  NEWZ*** NEWZ***  NETH NETH 
           
UK*** FIN***  NORW*** FIN***  IRE*** IRE***  US US 
NEWZ*** UK***  UK*** UK**  FRAN*** DEN***  UK UK 
IRE*** IRE***  IRE*** IRE  BELG*** FRAN**  AUST AUST*** 
BELG*** BELG***  BELG** BELG  GERM*** BELG**  BELG DEN*** 
AUST*** AUST***  AUST* AUST  DEN*** GERM  GERM* BELG*** 
           
PORT*** GERM**  PORT US  FIN*** AUST  FIN* FIN*** 
GERM*** PORT  GERM GERM  AUST*** FIN  IRE* IRE*** 
DEN** DEN  US DEN  PORT US  PORT* GERM*** 
US US  DEN PORT  US PORT**  DEN*** PORT*** 
*** Significant at .001 level 
** Significant at .01 level 
* Significant at .05 level 
 
Some clear high and low performers stand out in these analyses. Switzerland and Sweden 
rank in the top five countries for all regressions run. The other frequently high performers 
include Iceland, Italy, the Netherlands, and France. For the health outcomes of females, 
Denmark, Germany, Portugal, and the US experience the lowest levels of efficiency. For male 
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health outcomes, Finland and Portugal consistently rank near the bottom. While some of the 
differences in health outcomes may be statistically insignificant, the consistency of the rankings 
provides an indication of countries that are consistently performing well, and those that are not. 
In almost all of the regressions, the rank of the US appears to be low; the one clear 
exception is in the life expectancy of males at age 60 in which the US ranks near the middle 
rather than at or near the bottom. The difference in health outcomes for males over 60 could be 
explained by the strength of the US health care system in diagnosing and treating cardio vascular 
issues as well as prostate cancer (Preston and Ho, 2009). Overall however, these results indicate 
that the US health care system may be performing inefficiently. 
It is important to note that taking sugar consumption into consideration alters both the 
rank and significance of several of the countries included in the study. After taking sugar into 
account, the difference between the health outcomes of the US and its peers seems to grow 
smaller. These results support the hypothesis that the poor dietary habits regular in the US could 
be contributing to the lower life expectancies of its citizens rather than the entirety of the blame 
being placed on an inefficient health care system.  
As mentioned in Section III, the main issue with using country dummy coefficients in an 
OLS regression to indicate health care efficiency is that the dummy variables pick up all effects 
not accounted for in the model. Because variables for education and pollution could not be 
included, these as well as other potential influences on life expectancy such as crime rates and 
natural disasters that are outside of the control of health care are absorbed into the efficiency 
estimates. It is therefore desirable to perform an analysis that does not rely on country dummy 
variables to generate efficiency estimates. This is done here through SFA and the results are 
given in the next section. 
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Section V.II: Stochastic Frontier Analysis (SFA) Results 
 As explained in the Section III, SFA breaks down the regression residuals into two 
components, one due to model error which is assumed to be normally distributed with zero 
mean, and one due to inefficiency which is assumed in this analysis to have a truncated normal 
distribution with mean µ. While the coefficients of the independent variables are again, not the 
most important factor in this analysis, the results are fairly consistent with their OLS 
counterparts. Again, the regressions including LnPhys as the proxy for labor do not provide as 
strong results as those using LnGenPract and so only the results with LnGenPRact are discussed 
below. Full results can be seen in tables A3 and A4 in the appendix. 
While the signs and significance of most coefficients are consistent with those of the OLS 
regressions, there are a few variances in the coefficients of the independent variables for life 
expectancies of males. Alcohol consumption now has a significant negative impact on life 
expectancies both at birth and at age 60 and general practitioners no longer have a significant 
effect on life expectancies at birth.  The sizes of the coefficients however are not largely different 
from their OLS counterparts, suggesting that the differences in significance could be due to the 
relatively small effect these variables have on health outcomes for men. Despite these slightly 
problematic results, the important part of this analysis involves the efficiency estimates derived 
from the model residuals. Table 4 lists the countries ranked in order of the efficiency estimates 
generated in the analysis. 
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Table 4: Efficiency Rankings from SFA Results 
LEFB LEF60 LEMB LEM60 
No Sugar Sugar No Sugar Sugar No Sugar Sugar No Sugar Sugar 
SWITZ SWITZ SWITZ SWITZ ICE ICE ICE ICE 
ITAL SWED FRAN FRAN SWED SWED SWITZ SWITZ 
FRAN ITAL ITAL ITAL ITAL SWITZ SWED SWED 
SWED FRAN SWED IRE SWITZ IRE ITAL ITAL 
ICE ICE CAND SWED IRE ITAL CAND CAND 
FIN IRE IRE ICE NORW NORW FRAN US 
IRE FIN FIN CAND NETH DEN NORW FRAN 
NORW NORW ICE FIN CAND GERM US IRE 
NETH NETH NORW US GERM NETH IRE NORW 
CAND GERM NETH GERM FRAN US GERM DEN 
GERM CAND GERM DEN DEN FRAN AUS GERM 
UK DEN US NETH UK CAND DEN FIN 
AUS US DEN NORW AUS FIN FIN NEW 
DEN NEW NEW NEW FIN UK NEW AUS 
NEW UK AUS AUS NEW NEW PORT NETH 
PORT AUS PORT UK US AUS NETH UK 
BELG BELG UK BELG BELG BELG UK BELG 
US PORT BELG PORT PORT PORT BELG PORT 
AUST AUST AUST AUST AUST AUST AUST AUST 
 
Overall, the countries that rank in the top five for efficiency estimates are consistent with 
the results of the previous regressions. Italy, Switzerland, and Sweden rank in the top five 
countries for all regressions run. The other frequently high performers again include Iceland and 
France while the Netherlands has moved to a lower performance group. The lowest performers 
experience a slight change from the previous estimates, with Austria, Belgium, and Portugal in 
the lower quartile for all regressions. While the ranking of the high efficiency performers 
remained largely the same, the rank of the countries below the first quartile seems to have 
shifted. 
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There are a few important differences between the efficiency estimates generated through 
SFA and those generated from the OLS regressions; the most important difference being in the 
ranking of the US. In regressions including sugar consumption, the US ranks in the second 
highest quartile of the countries regressed for all life expectancy measures other than female life 
expectancy at birth. The difference in results between the SFA and OLS models suggest that 
differences in health outcomes for the US could be due more to excluded variable bias rather 
than inefficiency. This is further supported from the fact that taking sugar into account increases 
the rank of the US by two to six positions. The impact of sugar on efficiency estimates for the 
US health care system suggests that a portion of the difference in health outcomes between the 
US and its peers is because of the poor diet of its citizens which could be outweighing the 
benefits of its health care system. 
The SFA efficiency estimates can be found in tables A5 and A6 in the appendix. The 
analysis assumes that most countries are performing efficiently so the efficiency estimates for 
life expectancy of females and males at birth only range from about 95% to above 99%; the 
estimates for life expectancy at age 60 range from about 90% to above 99%. The variation in 
efficiency among countries is therefore sometimes quite small. There is no indication of the 
significance level of these differences so some of the variation may be arbitrary, as in the 
previous regressions. Also, although the US is ranked much higher in these estimates, it is still 
not ranked at the top which is still an indication of inefficiency in comparison to its peers. 
While time invariant SFA is more econometrically sound than relying on country dummy 
coefficients for estimates of efficiency, there are still drawbacks to this method. A key issue with 
the model is that it assumes that the efficiency estimates remain constant over time. This is 
unlikely given the large health benefits associated with increases in medical technology that 
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occur over time. Despite this flaw, SFA seems to generate fairly accurate efficiency results as 
further displayed by the consistency between the OLS and SFA results. 
 
Section VI: Conclusion 
 
As a whole, the OLS regressions explain a large portion of the variation in health 
outcomes, as measured by life expectancy, among the OECD nations studied. The significance 
levels of my variables in both the OLS and SFA models as well as the R2 values of the OLS 
regressions suggest that the results found here are fairly accurate. The consistency between the 
results of the OLS and SFA regressions also help confirm the validity of the models. 
The number of practicing general practitioners is found to have a more significant 
positive effect on life expectancy than the total number of practicing physicians, suggesting that 
increasing the number of general practitioners relative to specialists would have a positive effect 
on health outcomes. It therefore seems that it would be beneficial for countries to create 
incentives for medical students to choose careers as general practitioners rather than specialists 
which may mean alterations in the salary levels of specialists relative to those of general 
practitioners. 
Smoking is found to have the largest impact on health outcomes suggesting that the 
negative effects of smoking greatly decrease health outcomes, even when taking positive health 
care factors into consideration. This implies that stricter regulation on the contents of tobacco 
products as well as the ease of purchase of these products may be necessary to improve the 
health outcomes of a nation. 
Sugar consumption is found to have a significant negative effect on health outcomes. 
Taking sugar consumption into account increases the efficiency of the US, drastically in SFA 
results for life expectancy at birth for males and females. This suggests that a portion of the poor 
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health outcomes of the US is likely due to poor diet rather than health care system inefficiency. 
However, even when taking sugar consumption into account, the findings suggest that the US 
health care system is still performing inefficiently in comparison to some of its peers. While it is 
possible that taking more lifestyle controls into account may further increase the efficiency of the 
US, it is also possible given the results that some of the difference in US health outcomes is in 
fact due to inefficiency in the health care system.  
The policy implications of these results are often considered unappealing in the political 
world as they involve increasing government regulation and programs in health care. If these 
results are correct, the US needs to analyze its productive efficiency in health care relative to that 
of other nations. It is likely that a change in the system to one that is more generally followed in 
other nations may be appropriate. While pollution and education levels, along with other outside 
effects are unaccounted for in my model, the variables that are accounted for do not absorb 
enough of the negative health outcomes experienced by the US relative to its peers to remove the 
entirety of the blame from an inefficient health care system.  
 
Section VII: Avenues for Further Research 
 
 While the results found here are fairly consistent with high descriptive merit, there is still 
much to be improved upon in this field of research. There was not sufficient evidence to suggest 
diagnostic issues in the OLS regressions, but it is important to take into consideration that the US 
is an outlier among its peers in total health expenditure. Including the US in the analysis could 
therefore skew the estimated effects of health expenditure on life expectancy. Excluding the US 
from this analysis was not possible, given that the focus of the research was on the efficiency of 
the US health care system. Finding a way to generate efficiency estimates for the US without 
explicitly including it in the analysis could possibly generate more accurate results. 
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Other aspects of the research could be improved upon as well in order to generate more 
accurate estimates of efficiency. Finding proxies for other factors that affect health outcomes 
such as education, pollution, and external causes of death is imperative to this goal. Improving 
upon the econometric methods of the analysis could also help, particularly by relaxing the 
assumption of time-invariant efficiency in the SFA regressions.  
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Appendix 
Table A1: Regression Results with LnGenPract as an Independent Variable 
 lnLEFB lnLEF60 lnLEMB lnLEM60 
Variable No Sugar Sugar No Sugar Sugar No Sugar Sugar No Sugar Sugar 
(Constant) 4.600*** 4.685*** 3.694*** 3.848*** 4.722*** 4.808*** 4.065*** 4.187*** 
         
LnGenPract 0.011*** 0.012*** 0.036*** 0.044*** 0.004 0.008* 0.008 0.022** 
LnHealthExp 0.027*** 0.030*** 0.046*** 0.057*** 0.027*** 0.030*** 0.046*** 0.057*** 
         
LnGDP 0.008*** 0.006*** 0.017*** 0.014*** -0.002 -0.004** -0.015*** -0.016*** 
LnAgeDep -0.038*** -0.040*** -0.063*** -0.062*** -0.034*** -0.036*** -0.045* -0.041* 
         
LnAlcohol -0.009** -0.011** -0.031*** -0.042*** -0.005 -0.007 -0.003 -0.014 
LnTobacco -0.052*** -0.054*** -0.137*** -0.130*** -0.115*** -0.114*** -0.325*** -0.307*** 
LnSugar ---- -0.016*** ---- -0.040*** ---- -0.018*** ---- -0.045*** 
         
AUS 0.037*** 0.033*** 0.061*** 0.051*** 0.042*** 0.035*** 0.039*** 0.023* 
AUST 0.021*** 0.014*** 0.017* 0.002 0.017*** 0.007 -0.011 -0.031*** 
BELG 0.024*** 0.017*** 0.025** 0.007 0.024*** 0.013** -0.015 -0.041*** 
CAND 0.038*** 0.033*** 0.067*** 0.055*** 0.041*** 0.034*** 0.051*** 0.036*** 
DEN 0.010** 0.007 -0.011 -0.013 0.019*** 0.016*** -0.036*** -0.039*** 
FIN 0.038*** 0.029*** 0.053*** 0.028*** 0.017*** 0.007 -0.019* -0.043*** 
         
FRAN 0.047*** 0.038*** 0.100*** 0.079*** 0.027*** 0.014** 0.040*** 0.012 
GERM 0.020*** 0.009** 0.012 -0.011 0.020*** 0.007 -0.018* -0.047*** 
ICE 0.042*** 0.039*** 0.056*** 0.051*** 0.065*** 0.064*** 0.092*** 0.090*** 
IRE 0.033*** 0.025*** 0.036*** 0.021 0.033*** 0.023*** -0.025* -0.045*** 
ITAL 0.048*** 0.036*** 0.086*** 0.058*** 0.046*** 0.032*** 0.043*** 0.012 
NETH 0.044*** 0.041*** 0.074*** 0.072*** 0.047*** 0.043*** 0.012 0.009 
         
NEWZ 0.033*** 0.029*** 0.056*** 0.051*** 0.036*** 0.030*** 0.023** 0.013 
NORW 0.037*** 0.030*** 0.048*** 0.029*** 0.044*** 0.035*** 0.037*** 0.012 
PORT 0.020*** 0.007 0.014 -0.017 0.000 -0.018** -0.026* -0.065*** 
SWED 0.051*** 0.046*** 0.078*** 0.069*** 0.063*** 0.058*** 0.071*** 0.063*** 
SWITZ 0.058*** 0.057*** 0.125*** 0.128*** 0.057*** 0.056*** 0.083*** 0.088*** 
UK 0.034*** 0.028*** 0.037*** 0.025** 0.041*** 0.033*** -0.002 -0.019 
         
R
2
 .9606 .9611 .9649 .9666 .9715 .9705 .9680 .9686 
n 484 414 458 404 469 414 458 404 
*** Significant at .001 level 
** Significant at .01 level 
* Significant at .05 level 
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Table A2: Regression Results with LnPhys as an Independent Variable 
 lnLEFB lnLEF60 lnLEMB lnLEM60 
Variable No Sugar Sugar No Sugar Sugar No Sugar Sugar No Sugar Sugar 
(Constant) 4.658*** 4.722*** 3.650*** 3.701*** 4.913*** 4.953*** 4.496*** 4.530*** 
         
LnPhys 0.005 0.005 0.042*** 0.052*** -0.014** -0.012* -0.033* -0.029* 
LnHealthExp 0.016*** 0.018*** 0.033*** 0.037*** 0.009* 0.012** -0.014 -0.002 
         
LnGDP 0.010*** 0.009*** 0.022*** 0.019*** 0.000 -0.001 -0.003 -0.004 
LnAgeDep -0.041*** -0.044*** -0.058*** -0.057*** -0.054*** -0.056*** -0.072*** -0.071*** 
         
LnAlcohol -0.027*** -0.028*** -0.074*** -0.077*** -0.025*** -0.025*** -0.084*** -0.091*** 
LnTobacco -0.048*** -0.050*** -0.105*** -0.099*** -0.121*** -0.120*** -0.329*** -0.313*** 
LnSugar ---- -0.011** ---- -0.018* ---- -0.010* ---- -0.024* 
         
AUS 0.039*** 0.036*** 0.077*** 0.072*** 0.039*** 0.035*** 0.030** 0.025* 
AUST 0.026*** 0.021*** 0.035*** 0.026** 0.020*** 0.014*** 0.004 -0.005 
BELG 0.030*** 0.025*** 0.039*** 0.028** 0.030*** 0.025*** -0.002 -0.010 
CAND 0.035*** 0.031*** 0.068*** 0.064*** 0.034*** 0.030*** 0.028*** 0.023* 
DEN 0.008* 0.005 -0.013 -0.018* 0.020*** 0.016*** -0.029* -0.033** 
FIN 0.035*** 0.027*** 0.057*** 0.034** 0.014** 0.007 -0.027* -0.047** 
         
FRAN 0.059*** 0.053*** 0.130*** 0.118*** 0.042*** 0.035*** 0.087*** 0.078*** 
GERM 0.025*** 0.018*** 0.026*** 0.013 0.026*** 0.018*** 0.000 -0.012 
ICE 0.029*** 0.027*** 0.019* 0.012 0.055*** 0.054*** 0.060*** 0.055*** 
IRE 0.027*** 0.021*** 0.023* 0.009 0.028*** 0.020*** -0.038** -0.055*** 
ITAL 0.044*** 0.035*** 0.066*** 0.047*** 0.046*** 0.038*** 0.042** 0.026 
NETH 0.036*** 0.034*** 0.050*** 0.047*** 0.044*** 0.040*** 0.005 -0.002 
         
NEWZ 0.029*** 0.026*** 0.055*** 0.051*** 0.028*** 0.024*** 0.001 -0.005 
NORW 0.029*** 0.025*** 0.022** 0.013 0.041*** 0.037*** 0.006 -0.009 
PORT 0.032*** 0.022*** 0.048*** 0.030** 0.009 0.000 0.006 -0.008 
SWED 0.032*** 0.028*** 0.029*** 0.020** 0.052*** 0.048*** 0.036*** 0.025* 
SWITZ 0.046*** 0.044*** 0.083*** 0.078*** 0.054*** 0.050*** 0.085*** 0.080*** 
UK 0.027*** 0.022*** 0.032*** 0.026** 0.028*** 0.023*** -0.038*** -0.050*** 
         
R
2
 .9533 .9497 .9609 .9603 .9622 .9589 .9475 .9446 
n 531 474 514 458 531 474 519 463 
*** Significant at .001 level 
** Significant at .01 level 
* Significant at .05 level 
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Table A3: SFA Results with LnGenPract as an Independent Variable 
 lnLEFB lnLEF60 lnLEMB lnLEM60 
Variable No Sugar Sugar No Sugar Sugar No Sugar Sugar No Sugar Sugar 
(Constant) 4.667*** 4.751*** 3.833*** 3.988*** 4.790*** 4.872*** 4.152*** 4.266*** 
         
LnGenPract 0.008* 0.009*** 0.032*** 0.039*** 0.001 0.005 0.002 0.016* 
LnHealthExp 0.027*** 0.029*** 0.046*** 0.056*** 0.026*** 0.029*** 0.045*** 0.057*** 
         
LnGDP 0.008*** 0.007*** 0.017*** 0.015*** -0.001 -0.003* -0.013*** -0.014*** 
LnAgeDep -0.040*** -0.040*** -0.065*** -0.064*** -0.033*** -0.035*** -0.042* -0.039* 
         
LnAlcohol -0.010** -0.012*** -0.033*** -0.044*** -0.008* -0.010** -0.011 -0.021* 
LnTobacco -0.052*** -0.055*** -0.138*** -0.132*** -0.115*** -0.114*** -0.324*** -0.306*** 
LnSugar ---- -0.016*** ---- -0.040*** ---- -0.017*** ---- -0.043*** 
*** Significant at .001 level 
** Significant at .01 level 
* Significant at .05 level 
 
Table A4: SFA Results with LnPhys as an Independent Variable 
 lnLEFB lnLEF60 lnLEMB lnLEM60 
Variable No Sugar Sugar No Sugar Sugar No Sugar Sugar No Sugar Sugar 
(Constant) 4.715*** 4.775*** 3.783*** 3.822*** 4.961*** 4.988*** 4.553*** 4.562*** 
         
LnPhys 0.007 0.008 0.045*** 0.055*** -0.012* -0.010* -0.025 -0.020 
LnHealthExp 0.015*** 0.017*** 0.032*** 0.037*** 0.008 0.012** -0.012 0.001 
         
LnGDP 0.010*** 0.009*** 0.021*** 0.018*** 0.001 0.000 -0.004 -0.005 
LnAgeDep -0.041*** -0.043*** -0.059*** -0.057*** -0.053*** -0.054*** -0.070*** -0.070*** 
         
LnAlcohol -0.026*** -0.027*** -0.071*** -0.074*** -0.027*** -0.027*** -0.084*** -0.091*** 
LnTobacco -0.047*** -0.049*** -0.105*** -0.099*** -0.119*** -0.117*** -0.323*** -0.305*** 
LnSugar ---- -0.012*** ---- -0.019* ---- -0.008* ---- -0.021 
*** Significant at .001 level 
** Significant at .01 level 
* Significant at .05 level 
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Table A5: SFA Efficiency Estimates from Regressions with LnGenPract as an Independent Variable 
 
LEFB 
 
LEF60 
 
LEMB 
 
LEM60 
Country No Sugar Sugar 
 
No Sugar Sugar 
 
No Sugar Sugar 
 
No Sugar Sugar 
AUS 0.98638 0.98494 
 
0.95294 0.94799 
 
0.98491 0.98129 
 
0.96397 0.95554 
AUST 0.96846 0.96594 
 
0.90308 0.89735 
 
0.95869 0.95428 
 
0.91220 0.90341 
BELG 0.98337 0.97985 
 
0.94599 0.93556 
 
0.97939 0.97394 
 
0.94477 0.93169 
CAND 0.98950 0.98794 
 
0.97761 0.97505 
 
0.98675 0.98411 
 
0.98447 0.98116 
DEN 0.98577 0.98793 
 
0.95900 0.96558 
 
0.98653 0.98856 
 
0.96220 0.96874 
FIN 0.99350 0.99210 
 
0.97464 0.97132 
 
0.98375 0.98385 
 
0.96218 0.96239 
FRAN 0.99734 0.99485 
 
0.99102 0.98433 
 
0.98660 0.98451 
 
0.98236 0.97595 
GERM 0.98885 0.98926 
 
0.96421 0.96721 
 
0.98673 0.98709 
 
0.96643 0.96799 
ICE 0.99423 0.99484 
 
0.97409 0.97716 
 
0.99896 0.99897 
 
0.99713 0.99728 
IRE 0.99331 0.99409 
 
0.97580 0.97984 
 
0.99172 0.99253 
 
0.96954 0.97519 
ITAL 0.99811 0.99521 
 
0.99023 0.98295 
 
0.99585 0.99247 
 
0.98857 0.98140 
NETH 0.99041 0.99001 
 
0.96423 0.96400 
 
0.98778 0.98704 
 
0.94672 0.94978 
NEW 0.98556 0.98561 
 
0.95707 0.95798 
 
0.98255 0.98190 
 
0.95828 0.95832 
NORW 0.99106 0.99014 
 
0.96520 0.96355 
 
0.99013 0.98899 
 
0.97325 0.96972 
PORT 0.98413 0.97794 
 
0.94896 0.93396 
 
0.97171 0.96363 
 
0.94868 0.93155 
SWED 0.99705 0.99592 
 
0.98039 0.97936 
 
0.99827 0.99731 
 
0.98959 0.98883 
SWITZ 0.99890 0.99863 
 
0.99610 0.99590 
 
0.99284 0.99254 
 
0.99080 0.99481 
UK 0.98658 0.98520 
 
0.94840 0.94610 
 
0.98590 0.98358 
 
0.94580 0.94308 
US 0.98310 0.98658 
 
0.96235 0.96894 
 
0.98085 0.98467 
 
0.97233 0.97763 
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Table A6: SFA Efficiency Estimates from Regressions with LnPhys as an Independent Variable 
 
LEFB 
 
LEF60 
 
LEMB 
 
LEM60 
Country No Sugar Sugar 
 
No Sugar Sugar 
 
No Sugar Sugar 
 
No Sugar Sugar 
AUS 0.98266 0.98637 
 
0.95505 0.96332 
 
0.98748 0.98789 
 
0.95374 0.95857 
AUST 0.96657 0.97020 
 
0.90673 0.91677 
 
0.96690 0.96756 
 
0.91854 0.92407 
BELG 0.97808 0.97893 
 
0.93561 0.93681 
 
0.98267 0.98137 
 
0.93740 0.93703 
CAND 0.98312 0.98606 
 
0.97154 0.97699 
 
0.98588 0.98672 
 
0.97333 0.97654 
DEN 0.98375 0.98762 
 
0.95496 0.96546 
 
0.98906 0.99122 
 
0.96361 0.97136 
FIN 0.99556 0.99691 
 
0.98678 0.99054 
 
0.99322 0.99537 
 
0.98056 0.98658 
FRAN 0.99850 0.99861 
 
0.99602 0.99650 
 
0.99410 0.99384 
 
0.99573 0.99604 
GERM 0.98811 0.99067 
 
0.96422 0.97286 
 
0.99039 0.99173 
 
0.96973 0.97596 
ICE 0.97571 0.98108 
 
0.92928 0.94146 
 
0.99832 0.99862 
 
0.97560 0.97906 
IRE 0.98855 0.99142 
 
0.96318 0.97197 
 
0.99106 0.99232 
 
0.95904 0.96674 
ITAL 0.99569 0.99491 
 
0.98359 0.98233 
 
0.99766 0.99662 
 
0.98760 0.98621 
NETH 0.98487 0.98838 
 
0.95008 0.95971 
 
0.99303 0.99354 
 
0.94928 0.95482 
NEW 0.97787 0.98216 
 
0.94538 0.95603 
 
0.98148 0.98301 
 
0.94003 0.94735 
NORW 0.97215 0.97651 
 
0.90649 0.91905 
 
0.98664 0.98656 
 
0.92665 0.92967 
PORT 0.98488 0.98309 
 
0.95615 0.95380 
 
0.97772 0.97528 
 
0.95762 0.95535 
SWED 0.97882 0.98150 
 
0.92519 0.93322 
 
0.99665 0.99582 
 
0.95876 0.95997 
SWITZ 0.98445 0.98925 
 
0.94833 0.95932 
 
0.99848 0.99815 
 
0.99167 0.99372 
UK 0.97994 0.98271 
 
0.94057 0.94977 
 
0.98407 0.98461 
 
0.92759 0.93269 
US 0.98285 0.98784 
 
0.96198 0.97264 
 
0.98438 0.98824 
 
0.97393 0.98083 
 
 
 
